全文获取类型
收费全文 | 32534篇 |
免费 | 2919篇 |
国内免费 | 1916篇 |
专业分类
耳鼻咽喉 | 269篇 |
儿科学 | 342篇 |
妇产科学 | 380篇 |
基础医学 | 3711篇 |
口腔科学 | 498篇 |
临床医学 | 4543篇 |
内科学 | 5100篇 |
皮肤病学 | 252篇 |
神经病学 | 1879篇 |
特种医学 | 1293篇 |
外国民族医学 | 24篇 |
外科学 | 3176篇 |
综合类 | 5172篇 |
现状与发展 | 5篇 |
一般理论 | 16篇 |
预防医学 | 2425篇 |
眼科学 | 713篇 |
药学 | 3293篇 |
14篇 | |
中国医学 | 1699篇 |
肿瘤学 | 2565篇 |
出版年
2024年 | 70篇 |
2023年 | 370篇 |
2022年 | 1034篇 |
2021年 | 1363篇 |
2020年 | 1024篇 |
2019年 | 903篇 |
2018年 | 1022篇 |
2017年 | 924篇 |
2016年 | 934篇 |
2015年 | 1443篇 |
2014年 | 1685篇 |
2013年 | 1586篇 |
2012年 | 2587篇 |
2011年 | 2679篇 |
2010年 | 1868篇 |
2009年 | 1577篇 |
2008年 | 2028篇 |
2007年 | 2043篇 |
2006年 | 2059篇 |
2005年 | 1844篇 |
2004年 | 1374篇 |
2003年 | 1351篇 |
2002年 | 1134篇 |
2001年 | 620篇 |
2000年 | 562篇 |
1999年 | 510篇 |
1998年 | 310篇 |
1997年 | 334篇 |
1996年 | 280篇 |
1995年 | 267篇 |
1994年 | 231篇 |
1993年 | 161篇 |
1992年 | 195篇 |
1991年 | 160篇 |
1990年 | 146篇 |
1989年 | 90篇 |
1988年 | 88篇 |
1987年 | 77篇 |
1986年 | 62篇 |
1985年 | 60篇 |
1984年 | 58篇 |
1983年 | 22篇 |
1982年 | 26篇 |
1981年 | 23篇 |
1980年 | 16篇 |
1979年 | 14篇 |
1978年 | 11篇 |
1977年 | 9篇 |
1974年 | 9篇 |
1973年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
目的探讨低密度及氧化低密度脂蛋白对内皮细胞分泌肾上腺髓质素(ADM)的影响.方法利用培养的内皮细胞株ECV-304细胞,分别与不同浓度的低密度(50 100mg/L)、氧化低密度脂蛋白(50 100mg/L)及低密度脂蛋白(50 mg/L) 氧化低密度脂蛋白(50 mg/L)进行孵育,24 h后分别收集培养上清及细胞,用放免分析检测上清及细胞内肾上腺髓质素的含量.结果低密度脂蛋白对肾上腺髓质素的分泌无影响,而氧化型低密度脂蛋白能明显刺激ADM的分泌,二者合用的作用接近于100mg/L的OX-LDL.结论OX-LDL可能具有氧化LDL使其成为OX-LDL的作用,ADM的分泌可能是对细胞损伤的一种反应. 相似文献
62.
经尿道电切与气化切割和激光治疗前列腺增生症的疗效比较 总被引:11,自引:0,他引:11
目的 :比较经尿道电切前列腺术 (TURP) ,经尿道前列腺气化切除术 (TUVP)及经尿道接触式激光前列腺切除术 (TULP)的治疗效果。方法 :在 30 0 0例前列腺增生症患者中 ,按三种术式各随机抽取 2 0例术前条件具有可比性的患者 ,进行疗效比较。结果 :3种术式患者手术前后前列腺症状评分 (IPSS)、生活质量评分(QOL)、最大尿流率 (MFR)、剩余尿 (PVR)比较均得到显著改善 (P <0 .0 1) ,3组之间相比差异无显著性意义(P >0 .0 5 )。手术时间 :TUVP及TURP组明显短于TULP组 (P <0 .0 1) ,术中失血量及术后置管时间 :TUVP及TULP组明显少于TURP组 (P <0 .0 1)。TURP组术后继发感染、出血、暂时性尿失禁发生率少于TUVP及TULP组。结论 :3种术式治疗效果相同 ;TUVP操作简单、安全 ,对初学者来说尤其适宜 ;TURP仍为治疗BPH的金标准术式 相似文献
63.
左旋氨氯地平治疗轻中度高血压疗效及不良反应的临床研究 总被引:14,自引:0,他引:14
目的:为评价左旋氨氯地平降压疗效及不良反应,并与氨氯地平相比较。方法:采用随机分组平行对照方法,将120例轻、中度高血压患者分成左旋氨氯地平组(60例),口服2.5~5mg·d~(-1)和氨氯地平组(60例),口服5~10mg·d~(-1)。观察5周。每周一次上午延迟1~4小时用药并测诊室谷值坐位血压、心率、观察不良反应。结果:5周未左旋氨氯地平与氨氯地平组治疗有效反应率分别为86.7%和83.3%,每组治疗前后比较差异非常显著(P<0.01)。组间比无显著性差异(P>0.05)。左旋氨氯地平组不良反应发生率6.7%,氨氯地平组为16.7%(P>0.05),但试验组不良反应程度更轻微。结论:左旋氨氯地平与氨氯地平治疗高血压同样有效,不良反应可能更小。 相似文献
64.
Effect of Ligustrazine on Bone Marrow Microenvironment and Signal Transducti on Path in Irradiation Injured Mice 下载免费PDF全文
Lan Sun Wen-li Liu Han-ying Sun Tian-hua Ren Deng-ju Li Hui-zhen Xu Wu Lu 《中国结合医学杂志》2002,8(4):295-298
Wehavereported previouslythatligustrazinecouldpromotehematopoiesisthroughimprovingbonemarrowmicroenvironmentandenhancingadhesive 相似文献
65.
L H Ren A V Vasil'ev A N Orkehov V V Tertov V A Tutel'ian 《Farmakologiia i toksikologiia》1989,52(5):44-46
Administration of alizole, berberine, pheonol and pheoniphlorine in doses of 30-100 micrograms/ml in the culture of the atherosclerotic human aortic intimal cells decreased the content of intracellular cholesterol by 35-41% and reduced the proliferative activity of the cells. In healthy donors administration of single doses of berberine and pheoniphlorine (0.9 g) increased the antiatherogenic potential of the serum which was estimated on the primary culture of the intimal cells. 相似文献
66.
67.
Visfatin was expressed in rat anti mouse islets,as well as in MIN6 cells. The visfatin expression was affected by various concentrations of environmental glucose (5.5 and 33.3 mmoL/L) and palmitate(0.5 mmol/L). As compared with low-level glucose medium (5.5 mmol/L, 1.0±0.11) , visfatin expression increased in media with high glucose and palmitate (1.32 ±0. 18, 1. 33±0. 15,1.72±0.27, all P<0. 05). The result suggests that visfatin seems to be involved in the regulation of insulin secretion. 相似文献
68.
应用生理性成骨力值概念治疗骨折与骨不连——兼论MO现象与有效固定 总被引:2,自引:2,他引:0
张春才 禹宝庆 许硕贵 苏佳灿 王家林 牛云飞 康庆林 付青格 任可 张鹏 高堂成 张雪松 严望军 王冠军 汪光晔 万岷 李波 孙建伟 王仁 丛永健 杨郁野 郑医红 李格当 刘欣伟 管华鹏 《中国骨伤》2007,20(6):361-363
治疗骨折与术后合并的骨不连,至今仍是骨创伤领域的难题之一。研究分析当前的学术思想,探索更接近骨愈合规律的理念与技术,是必然的学术趋势。1当前骨创伤理论与技术1.1AO从20世纪50年代起,AO组织提出解剖复位与骨块间坚强固定与加压的概念。50年间,由于伴随生物材料学的发展和内固定形式的进步,业已成为治疗骨折与骨不连的主要理论与方法,并取得了瞩目的成就,但同时也发现了存在并需继续探讨的若干问题。(1)偏心类的固定模式,如加压钢板,其疗效超越一般非加压性钢板。但同时也发现:①内固定期间,骨质萎缩,骨痂纹理凌乱或难觅骨痂;②钢板… 相似文献
69.
A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. 总被引:3,自引:0,他引:3
Pavel Sova Xiao-Wei Ren Shaoheng Ni Kathrin M Bernt Jie Mi Nancy Kiviat André Lieber 《Molecular therapy》2004,9(4):496-509
We have constructed a new capsid-modified adenovirus (Ad) vector that specifically replicates in tumor cells and expresses TNF-related apoptosis-inducing ligand (TRAIL). The Ad capsid contains short-shafted fibers derived from Ad serotype 35, which allow for efficient infection of malignant tumor cells, and largely avoids innate toxicity after intravenous application. Replication-dependent homologous recombination in Ad genomes was used to achieve tumor-specific expression of Ad E1a (to mediate viral replication) and TRAIL (to mediate apoptosis and enhance release of progeny virus from infected cells). We demonstrated that our oncolytic vector (Ad5/35.IR-E1A/TRAIL) induced apoptosis in human tumor cell lines derived from colorectal, lung, prostate, and liver cancer. Both in vitro and in vivo tumor models showed efficient intratumoral spread of this vector. In a model for metastatic colon cancer, tail vein infusion of Ad5/35.IR-E1A/TRAIL resulted in elimination of preestablished liver metastases. Intravenous injection of this vector caused a transient elevation of serum glutamic pyruvic transaminase in tumor-bearing mice, which we attributed to factors released from apoptotic tumor cells. Liver histology analyzed at day 14 after virus injection did not show signs of hepatocellular damage. This new oncolytic vector represents a potentially efficient means for gene therapy of metastatic cancer. 相似文献
70.
Defective implant osseointegration under protein undernutrition: prevention by PTH or pamidronate. 总被引:1,自引:0,他引:1
Romain Dayer Isabelle Badoud René Rizzoli Patrick Ammann 《Journal of bone and mineral research》2007,22(10):1526-1533
Protein deficiency is associated with impaired titanium osseointegration. We studied whether systemic treatment with PTH or pamidronate could influence the resistance to pull-out of titanium rods implanted into rats proximal tibia under normal and isocaloric low protein intake. PTH or pamidronate prevented the deleterious effects of protein undernutrition on bone microarchitecture close to the implant and on mechanical fixation. PTH even significantly improved implant osseointegration. INTRODUCTION: Protein deficiency is highly prevalent among elderly patients hospitalized in orthopedic wards. Reduced protein intake impairs titanium osseointegration in rats. Whether stimulator of bone formation or inhibitor of bone resorption could improve implant osseointegration under protein deprivation is not known. We studied the effects of systemic treatment with PTH or pamidronate on the resistance to pull-out of titanium rods implanted into rats proximal tibia under normal and isocaloric low protein intake. MATERIALS AND METHODS: We measured the resistance to pull-out 1-mm-diameter titanium rods implanted into the proximal tibias of 49 adult female rats receiving a normal or an isocaloric low protein diet. After 2 wk on either diet, the implants were inserted, and the rats received PTH(1-34), pamidronate or saline vehicle for 8 wk. The tibias were removed for microCT morphometry, followed by the evaluation of pull-out strength. RESULTS: Pull-out strength was lower in rats fed an isocaloric low protein diet compared with rats fed a normal protein intake (-29%). PTH and pamidronate significantly increased pull-out strength in animals fed a normal or a low protein diet, the effect of PTH being of higher magnitude. The PTH- or pamidronate-mediated increase in pull-out strength was associated with significant increases of relative bone volume, bone-to-implant contact, and trabecular thickness, whereas trabecular spacing was reduced, in the vicinity of the implants. CONCLUSIONS: We confirmed that isocaloric low protein intake impairs titanium implant osseointegration. PTH or pamidronate prevented the deleterious effects of protein undernutrition and even significantly improved the implant osseointegration. These results indicate that systemic administration of PTH or pamidronate could be considered for preventing uncemented arthroplasty loosening in protein undernourished patients. 相似文献